Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.

MLA

Yam, Jason C., et al. “Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.” Ophthalmology, vol. 127, no. 7, July 2020, pp. 910–19. EBSCOhost, https://doi.org/10.1016/j.ophtha.2019.12.011.

APA

Yam, J. C., Li, F. F., Zhang, X., Tang, S. M., Yip, B. H. K., Kam, K. W., Ko, S. T., Young, A. L., Tham, C. C., Chen, L. J., & Pang, C. P. (2020). Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology, 127(7), 910–919. https://doi.org/10.1016/j.ophtha.2019.12.011

Chicago

Yam, Jason C., Fen Fen Li, Xiujuan Zhang, Shu Min Tang, Benjamin H.K. Yip, Ka Wai Kam, Simon T. Ko, et al. 2020. “Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.” Ophthalmology 127 (7): 910–19. doi:10.1016/j.ophtha.2019.12.011.